Economic impact of the introduction of the ProC® global assay in the screening strategy of protein C pathway abnormalities in unselected patients with a history of venous thromboembolism

被引：0
|
作者：
Toulon, P [1 ]
Adda, R [1 ]
Perez, P [1 ]
机构：
[1] Hop Cochin, Hematol Lab, F-75679 Paris 14, France
来源：
THROMBOSIS AND HAEMOSTASIS | 2001年 / 86卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：720 / 721
页数：2
相关论文
共 33 条
  • [21] Long term experience with ProC global as screening assay for the total function of the protein C-system
    Siegemund, A
    THROMBOSIS AND HAEMOSTASIS, 1999, : 316 - 316
  • [22] Evaluation of a global screening assay for the investigation of the protein C anticoagulant pathway
    Rimmer, JE
    Cooper, PC
    Brookfield, CJ
    Preston, FE
    Makris, M
    CLINICAL AND LABORATORY HAEMATOLOGY, 2000, 22 (06): : 351 - 354
  • [23] Evaluation of ProC(R) Global - A new coagulo-metric screening test for the protein C pathway
    Odpadlik, M
    Bayer, PM
    Wagner, C
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS116 - PS116
  • [24] Clinical evaluation of a global screening assay to assess the protein C anticoagulant pathway.
    Hassett, ALC
    Rosenblum, E
    Bontempo, FA
    BLOOD, 1997, 90 (10) : 3217 - 3217
  • [25] ProC Global: A new functional screening assay sensitive for defects of protein C, protein S and factor V. First clinical data from thrombophilic patients
    Hafner, G
    Niemann, F
    Erbes, H
    Prellwitz, W
    Noah, M
    Kraus, M
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS117 - PS117
  • [26] An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients
    Ferroni, Patrizia
    Martini, Francesca
    Portarena, Ilaria
    Grenga, Italia
    Riondino, Silvia
    La Farina, Francesca
    Laudisi, Anastasia
    Roselli, Mario
    Guadagni, Fiorella
    THROMBOSIS AND HAEMOSTASIS, 2011, 105 (05) : 931 - 932
  • [27] HEREDITARY ANTITHROMBIN III-DEFICIENCY, PROTEIN-C-DEFICIENCY AND PROTEIN-S-DEFICIENCY - PREVALENCE IN PATIENTS WITH A HISTORY OF VENOUS THROMBOEMBOLISM AND SELECTION CRITERIA FOR AN OPTIMIZED PATIENT SCREENING
    PABINGER, I
    BRUCKER, S
    SPEISER, W
    KYRLE, PA
    LECHNER, K
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1045 - 1045
  • [28] A novel assay detecting abnormalities of anticoagulant protein C pathway using recombinant human thrombomodulin: Application on patients with diabetes mellitus
    Mohri, M
    Gabazza, EC
    Takeya, H
    Sata, M
    Yamamoto, S
    Suzuki, K
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1705 - P1705
  • [29] Sensitivity of a new global assay for protein C (PC) pathway abnormalities and potential significance of an abnormal test result as a risk factor/marker for thrombosis independently of its sensitivity for PC pathway abnormalities.
    Toulon, PA
    Rosencher, N
    Guigon, A
    Simon, A
    BLOOD, 2005, 106 (11) : 740A - 740A
  • [30] A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin
    Mahmoodi, B. K.
    Brouwer, J-L P.
    Ten Kate, M. K.
    Lijfering, W. M.
    Veeger, N. J. G. M.
    Mulder, A. B.
    Kluin-Nelemans, H. C.
    van der Meer, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (06) : 1193 - 1200
1234